• 1. An amphipathic trans-acting phosphorothioate RNA element delivers an uncharged phosphorodiamidate morpholino sequence in mdx mouse myotubes?
  H. V. Jain,D. Verthelyi,S. L. Beaucage RSC Adv., 2017,7, 42519-42528
• 2. An approach to C–N activation: coupling of arenesulfonyl hydrazides and arenesulfonyl chlorides with tert-amines via a metal-, oxidant- and halogen-free anodic oxidation??
  M. Sheykhan,S. Khani,S. Shaabanzadeh,M. Joafshan Green Chem., 2017,19, 5940-5948
• 3. An ionic liquid-based synergistic extraction strategy for rare earths?
  Yingbo Li,Nada Mehio,Huizhou Liu,Sheng Dai Green Chem., 2015,17, 2981-2993
• 4. An investigation on the second-order nonlinear optical response of cationic bipyridine or phenanthroline iridium(iii) complexes bearing cyclometallated 2-phenylpyridines with a triphenylamine substituent?
  David B. Cordes,Alexandra M. Z. Slawin,Stefania Righetto,Denis Jacquemin,Eli Zysman-Colman,Véronique Guerchais Dalton Trans., 2018,47, 8292-8300
• 5. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587

Recent Advances in the Study of (3-Methoxy-2-nitrophenyl)methanol (CAS: 53055-04-2) and Its Applications in Chemical Biology and Pharmaceutical Research

The compound (3-Methoxy-2-nitrophenyl)methanol (CAS: 53055-04-2) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This aromatic alcohol derivative, characterized by its methoxy and nitro functional groups, has demonstrated potential as a versatile intermediate in the synthesis of bioactive molecules. Recent studies have explored its utility in drug discovery, particularly in the development of novel therapeutic agents targeting inflammatory and oncological pathways. The compound's unique structural features enable its incorporation into more complex pharmacophores, enhancing binding affinity and selectivity.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers investigated the role of (3-Methoxy-2-nitrophenyl)methanol as a precursor in the synthesis of small-molecule inhibitors for protein kinases. The study highlighted its efficacy in forming stable covalent bonds with cysteine residues in the ATP-binding pocket of kinases, thereby inhibiting aberrant signaling pathways implicated in cancer progression. The researchers employed density functional theory (DFT) calculations to optimize the compound's reactivity, followed by in vitro assays to validate its inhibitory effects on tumor cell lines.

Another notable application of (3-Methoxy-2-nitrophenyl)methanol was reported in a recent ACS Chemical Biology article, where it was utilized as a key building block for the development of fluorescent probes. These probes were designed to detect reactive oxygen species (ROS) in live cells, offering insights into oxidative stress mechanisms associated with neurodegenerative diseases. The nitro group in the compound facilitated the probe's redox-sensitive properties, while the methanol moiety allowed for further functionalization with fluorophores. The study demonstrated high specificity and sensitivity in detecting ROS in neuronal models, paving the way for diagnostic applications.

Beyond its role in drug discovery and diagnostics, (3-Methoxy-2-nitrophenyl)methanol has also been explored in materials science. A 2024 Nature Communications paper detailed its incorporation into polymer matrices to create stimuli-responsive materials. The nitro group's photolabile nature enabled the development of light-triggered drug delivery systems, where the compound acted as a photocleavable linker. This innovation holds promise for targeted therapies, minimizing off-target effects and improving therapeutic outcomes.

Despite these advancements, challenges remain in the large-scale synthesis and purification of (3-Methoxy-2-nitrophenyl)methanol. A recent Organic Process Research & Development study addressed these issues by optimizing catalytic hydrogenation conditions to improve yield and reduce byproduct formation. The authors proposed a green chemistry approach using palladium-on-carbon catalysts under mild conditions, achieving a 90% yield with high purity. This methodological improvement is expected to facilitate broader adoption of the compound in industrial applications.

In conclusion, (3-Methoxy-2-nitrophenyl)methanol (CAS: 53055-04-2) represents a multifaceted tool in chemical biology and pharmaceutical research. Its applications span drug development, diagnostic probes, and advanced materials, underscoring its versatility. Future research should focus on expanding its utility in targeted therapies and exploring its potential in other disease models. The compound's unique properties and recent methodological advances position it as a valuable asset in the pursuit of innovative therapeutic solutions.

• 5345-42-6(1-methoxy-3-methyl-2-nitrobenzene)
• 3606-21-1(1-methoxy-5-methyl-2,4-dinitro-Benzene)
• 27508-87-8(1,5-DIMETHOXY-3-METHYL-2-NITROBENZENE)
• 18102-38-0(1-Methoxy-3,5-dimethyl-2-nitrobenzene)
• 108005-34-1(Benzene, 1-nitro-2-[(2-nitrophenoxy)methyl]-)
• 538316-04-0(Benzene, 1-methoxy-3-(methoxymethyl)-2-nitro- (9CI))
• 80866-88-2((3-methoxy-4-nitrophenyl)methanol)
• 19404-15-0(Benzene,2-methoxy-4-methyl-1,3,5-trinitro-)
• 5435-28-9(Benzenemethanol, 3,4,5-trimethoxy-2-nitro-)
• 61535-21-5(1-Benzyloxy-3-methyl-2-nitrobenzene)